News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
GADICKE ANSBERT
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/24/2023 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Sold 70,170 shares
@ $1.88, valued at
$131.9k
Exercised (in-or-at-the-money) 42,761 warrants
@ $0.74, valued at
$31.6k
Exercised (in-or-at-the-money) 135,508 warrants
@ $0.74, valued at
$100.3k
|
|
| 02/10/2023 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 08/01/2022 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on Allovir, Inc.|
Txns:
| Granted 3,253,796 shares
@ $4.61, valued at
$15M
|
|
| 06/23/2022 |
4
| GADICKE ANSBERT (Director) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Granted 16,475 options to buy
@ $12.73, valued at
$209.7k
|
|
| 05/19/2022 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on Allovir, Inc.|
Txns:
| Granted 27,500 options to buy
@ $4.6, valued at
$126.5k
|
|
| 03/25/2022 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Granted 7,800 options to buy
@ $28.8, valued at
$224.6k
|
|
| 01/06/2022 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 158,579 shares
@ $42.05, valued at
$6.7M
Sold 32,396 shares
@ $43.2, valued at
$1.4M
Sold 11,318 shares
@ $45.32, valued at
$512.9k
Sold 12,829 shares
@ $46.47, valued at
$596.2k
Sold 30,347 shares
@ $42.03, valued at
$1.3M
|
|
| 12/07/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 29,402 shares
@ $34.68, valued at
$1M
Sold 4,047 shares
@ $35.44, valued at
$143.4k
Sold 300 shares
@ $36.26, valued at
$10.9k
Sold 14,173 shares
@ $32.35, valued at
$458.5k
Sold 1,960 shares
@ $33.57, valued at
$65.8k
Sold 850 shares
@ $34.08, valued at
$29k
Sold 100 shares
@ $35.04, valued at
$3.5k
Sold 30,059 shares
@ $33.15, valued at
$996.5k
Sold 2,499 shares
@ $34.11, valued at
$85.2k
|
|
| 12/02/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 9,809 shares
@ $34.62, valued at
$339.6k
Sold 46,992 shares
@ $35.19, valued at
$1.7M
Sold 10,111 shares
@ $33.82, valued at
$342k
Sold 9,131 shares
@ $34.61, valued at
$316k
Sold 1,500 shares
@ $35.34, valued at
$53k
Sold 49,796 shares
@ $33.74, valued at
$1.7M
Sold 12,434 shares
@ $34.83, valued at
$433.1k
|
|
| 11/30/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 10,952 shares
@ $35.49, valued at
$388.7k
Sold 10,258 shares
@ $36.03, valued at
$369.6k
Sold 16,856 shares
@ $34.46, valued at
$580.9k
Sold 500 shares
@ $35.37, valued at
$17.7k
|
|
| 11/24/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Disposed of 15,671 shares
@ $0
Sold 15,575 shares
@ $37.16, valued at
$578.8k
Sold 19,758 shares
@ $37.81, valued at
$747k
Sold 32,876 shares
@ $36.21, valued at
$1.2M
Sold 600 shares
@ $36.5, valued at
$21.9k
Sold 8,147 shares
@ $35.2, valued at
$286.8k
Sold 30,696 shares
@ $36.05, valued at
$1.1M
Sold 21,965 shares
@ $37.02, valued at
$813.1k
|
|
| 11/04/2021 |
4
| MPM BioVentures 2014, L.P. (10% Owner) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Converted 3,816,760 shares
@ $0
Converted 509,024 shares
@ $0
Bought 100,000 shares
@ $20, valued at
$2M
Converted 27,617,675 preferred shares
@ $0
Converted 3,683,241 preferred shares
@ $0 |
|
| 10/28/2021 |
3
| MPM BioVentures 2014, L.P. (10% Owner) has filed a Form 3 on Entrada Therapeutics, Inc. |
| 10/18/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 14,882 shares
@ $27.53, valued at
$409.7k
Sold 3,413 shares
@ $28.01, valued at
$95.6k
Sold 10,320 shares
@ $27.14, valued at
$280.1k
|
|
| 10/14/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 14,260 shares
@ $27.09, valued at
$386.3k
Sold 35,023 shares
@ $27.13, valued at
$950.2k
Sold 45,719 shares
@ $27.3, valued at
$1.2M
|
|
| 10/12/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 1,922 shares
@ $27, valued at
$51.9k
Sold 3,400 shares
@ $27.01, valued at
$91.8k
Sold 81,684 shares
@ $27.24, valued at
$2.2M
|
|
| 10/05/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 11,471 shares
@ $27, valued at
$309.7k
Sold 34,659 shares
@ $27.06, valued at
$937.9k
|
|
| 09/30/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 32,154 shares
@ $27, valued at
$868.2k
Sold 3,836 shares
@ $27, valued at
$103.6k
|
|
| 09/27/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 60,600 shares
@ $27.96, valued at
$1.7M
Sold 1,200 shares
@ $28.38, valued at
$34.1k
Sold 8,221 shares
@ $27.81, valued at
$228.6k
Sold 19,455 shares
@ $27.09, valued at
$527k
|
|
| 09/23/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 32,858 shares
@ $27.47, valued at
$902.6k
Sold 23,921 shares
@ $27.54, valued at
$658.8k
|
|
| 09/20/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 35,565 shares
@ $28.47, valued at
$1M
Sold 76,473 shares
@ $28.82, valued at
$2.2M
Sold 17,743 shares
@ $27.03, valued at
$479.6k
Sold 22,930 shares
@ $27.84, valued at
$638.4k
|
|
| 09/20/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 432 shares
@ $29.06, valued at
$12.6k
Sold 3,124 shares
@ $29.06, valued at
$90.8k
|
|
| 09/16/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 30,018 shares
@ $27.5, valued at
$825.5k
Sold 6,063 shares
@ $27.99, valued at
$169.7k
Sold 38,677 shares
@ $27.79, valued at
$1.1M
Sold 1,659 shares
@ $28.15, valued at
$46.7k
|
|
| 09/16/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 982 shares
@ $29.17, valued at
$28.6k
Sold 7,106 shares
@ $29.17, valued at
$207.3k
Sold 888 shares
@ $29.16, valued at
$25.9k
Sold 6,425 shares
@ $29.16, valued at
$187.4k
|
|
| 09/13/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 38,028 shares
@ $28.97, valued at
$1.1M
Sold 11,313 shares
@ $27.86, valued at
$315.2k
Sold 11,330 shares
@ $28.73, valued at
$325.5k
Sold 35,785 shares
@ $27.64, valued at
$989.1k
|
|
| 09/13/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 1,898 shares
@ $29.35, valued at
$55.7k
Sold 13,727 shares
@ $29.35, valued at
$402.9k
Sold 820 shares
@ $29.04, valued at
$23.8k
Sold 5,931 shares
@ $29.04, valued at
$172.2k
Sold 497 shares
@ $29.1, valued at
$14.5k
Sold 3,595 shares
@ $29.1, valued at
$104.6k
|
|
| 09/08/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 50,996 shares
@ $29.18, valued at
$1.5M
Disposed of 31,340 shares
@ $0
Sold 18,663 shares
@ $28.61, valued at
$533.9k
Sold 1,573 shares
@ $29.1, valued at
$45.8k
|
|
| 09/08/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 1,760 shares
@ $29.6, valued at
$52.1k
Sold 12,731 shares
@ $29.6, valued at
$376.8k
Sold 3,465 shares
@ $29.04, valued at
$100.6k
Sold 25,067 shares
@ $29.04, valued at
$727.9k
Sold 1,499 shares
@ $29.11, valued at
$43.6k
Sold 10,842 shares
@ $29.11, valued at
$315.6k
|
|
| 09/02/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 177 shares
@ $29.43, valued at
$5.2k
Sold 1,285 shares
@ $29.43, valued at
$37.8k
Sold 215 shares
@ $30.14, valued at
$6.5k
Sold 1,553 shares
@ $30.14, valued at
$46.8k
Sold 790 shares
@ $29.47, valued at
$23.3k
Sold 5,714 shares
@ $29.47, valued at
$168.4k
Sold 2,178 shares
@ $29.46, valued at
$64.2k
Sold 15,757 shares
@ $29.46, valued at
$464.2k
|
|
| 08/31/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 1,846 shares
@ $29.09, valued at
$53.7k
Sold 13,357 shares
@ $29.09, valued at
$388.6k
Sold 4,285 shares
@ $29.3, valued at
$125.6k
Sold 31,001 shares
@ $29.3, valued at
$908.3k
|
|
| 08/25/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 7,376 shares
@ $29.11, valued at
$214.7k
Sold 53,359 shares
@ $29.11, valued at
$1.6M
Sold 7,025 shares
@ $29.48, valued at
$207.1k
Sold 50,882 shares
@ $29.48, valued at
$1.5M
Sold 237 shares
@ $29.09, valued at
$6.9k
Sold 1,713 shares
@ $29.09, valued at
$49.8k
|
|
| 08/12/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 347 shares
@ $29.05, valued at
$10.1k
Sold 2,510 shares
@ $29.05, valued at
$72.9k
|
|
| 07/13/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Sold 4,067 shares
@ $33.06, valued at
$134.5k
Sold 57,301 shares
@ $33.58, valued at
$1.9M
Sold 711 shares
@ $34.1, valued at
$24.2k
|
|
| 06/30/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Sold 13,800 shares
@ $34.06, valued at
$470k
Sold 2,700 shares
@ $34.82, valued at
$94k
Sold 2,700 shares
@ $33.29, valued at
$89.9k
|
|
|
|
|